Reshaping pharmaceutical marketing: moment of truth
In this article I will try to highlight the disruptive acceleration in the field of pharmaceutical...
News
Reshaping pharmaceutical marketing: the agony of production frequency
The best reflections emerge from reading and especially discussing with those who disagree but have...
Reshaping pharmaceutical marketing: from doctors database to access map
The doctor database is only a company asset if it is qualified, correct, certified and above all...
Pharma Multichannel in Italy? Let's start with the basics
Let's start with the basics: pharma multichannel has no unambiguous definition, it is true. But it...
Reshaping pharmaceutical marketing, not using the heirloom box
Faced with the spread of the Sars-Cov-2 virus, the pharmaceutical industry is facing several...
Reshaping pharmaceutical marketing: we don't need a bigger hammer
There are problems that have at their root the choices we have made to solve them.
Reshaping pharmaceutical marketing: 'one size fits all' is gone forever
The evolution of pharma marketing in Italy is forcing marketers to face new challenges in content...
Reshaping pharmaceutical marketing: the Black Death and sunset starlings
An interesting scientific article on the collective behaviour of animals, i.e. on the coordinated...
Reshaping pharmaceutical marketing: the patient in the crosshairs?
Let's be honest, the 'patient at the centre' transition has sometimes been misrepresented by some...
Reshaping pharmaceutical marketing: read Istat and Censis and get it over with
The periodic report of Istat, to which I subscribe as a journalist, has recently been published....
Continue reading